Skip to the main content

Professional paper

Morbidity trends of musculosceletal diseases and antireumatic drug utilization: longitudinal study based on routinely collected data

Martina Menegoni ; Centar za hitnu medicinu, Opća bolnica “Dr. Josip Benčević” Slavonski Brod,
Leonard Lamot ; Dom zdravlja Krapinsko-zagorske županije, M. Crkvenca 1, Krapina
Dijana Dečman ; Dom zdravlja Krapinsko-zagorske županije, M. Crkvenca 1, Krapina
Gordana Prljević ; Ordinacija obiteljske medicine „Dr. Gordana Prljević“, Antuna Mihanovića 3, Krapinske Toplice
Mladenka Vrcić Keglević ; 4Zaklada za razvoj obiteljske medicine, Črešnjevec 32, Zagreb


Full text: croatian pdf 842 Kb

page 19-29

downloads: 689

cite


Abstract

Aim. This survey investigated ten-year morbidity trend of usculoskeletal diseases (MSD) registered in the Croatian primary health care (PHC) and trends in antirheumatic drug utilization.
Methods. Morbidity data (diagnoses M00-M99) registered in PHC for ten consecutive years were collected from the Croatian health service
yearbooks (2005-2014). Data on MSD (M01-M09) drug utilization were obtained from the Croatian Agency for Medical Products and Medical Devices annual reports.
Results. MSD were on the third place in total morbidity, with a growing tendency and a share of 8.6%-10.6% in total morbidity. They were
more frequent in the elderly, with back-pain as the leading diagnosis, followed by degenerative and inflammatory rheumatism. Only scoliosis
and osteoporosis showed decreasing tendency. Antirheumatic drug utilization are sharing morbidity trends, with an increase from 37.3 to 53.8 DDD and is in proportion with financial burden.
NSAIDs are the leading group of drugs with a share of 84%. Diclofenac and ibuprofen were prescribed most frequently, diclofenac with a decreasing, and ibuprofen with an increasing trend.
Conclusion. Growing trends in MSD morbidity and NSAIDs utilization will presumably continue in the future, with a relative decrease of higher risk drugs (diclofenac) and increase in lower risk drugs (ibuprofen).

Keywords

Anti-rheumatic agents; NSAIDs; musculoskeletal diseases; prevalence, primary health care; Croatia

Hrčak ID:

157224

URI

https://hrcak.srce.hr/157224

Publication date:

5.5.2016.

Article data in other languages: croatian

Visits: 1.838 *